ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,672.00
      -0.03%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.545
      0.51%
      Bitcoin
      57,053.77
      -0.51%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Global Blood Therapeutics Inc (GBT)

      7. Global Blood Therapeutics Inc (GBT) News

      GBT

      Global Blood Therapeutics (GBT)

      Global Blood Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GBT
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      09/06/20178:00AMGlobeNewswire Inc.Global Blood Therapeutics To Convene Sickle Cell Disease Influencers at Annual Sickle Cell Disease (SCD) Therapeutics Confer...NASDAQ:GBTGlobal Blood Therapeutics Inc
      09/05/20176:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      09/05/20176:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      09/05/20174:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      09/05/20178:00AMGlobeNewswire Inc.Global Blood Therapeutics Receives Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of Sickle Cell Diseas...NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/30/20174:05PMGlobeNewswire Inc.Global Blood Therapeutics Announces Upcoming Participation in Multiple Investor Conferences in SeptemberNASDAQ:GBTGlobal Blood Therapeutics Inc
      08/23/20174:08PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/09/20174:05PMGlobeNewswire Inc.Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare ConferenceNASDAQ:GBTGlobal Blood Therapeutics Inc
      08/07/20174:15PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/07/20174:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/07/20174:05PMGlobeNewswire Inc.Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial ResultsNASDAQ:GBTGlobal Blood Therapeutics Inc
      08/03/20174:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/03/20174:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/03/20174:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/03/20174:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/03/20174:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      08/01/20174:42PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      07/27/20175:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      07/26/20174:05PMGlobeNewswire Inc.Global Blood Therapeutics Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      07/25/20177:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      07/10/20178:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      07/10/20178:00AMGlobeNewswire Inc.Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric PopulationNASDAQ:GBTGlobal Blood Therapeutics Inc
      06/28/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/28/20178:00AMGlobeNewswire Inc.Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/23/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/23/20172:30AMGlobeNewswire Inc.Global Blood Therapeutics Announces New Data Supporting Ongoing Clinical Development of GBT440 in Adolescents with Sickle Ce...NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/22/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/16/20174:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/06/20174:05PMGlobeNewswire Inc.Global Blood Therapeutics Announces Participation at the Goldman Sachs 38th Annual Global Healthcare ConferenceNASDAQ:GBTGlobal Blood Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GBT